New Advances in HRS/AKI: Clinical Update and Expert Recommendations | March 6, 2023 | Odessa, TX
The 2023 New Advances in HRS/AKI: Clinical Update and Expert Recommendations will deliver focused, educational updates highlighting clinically relevant advances in the management of patients with HRS. Internationally renowned clinicians will lead the development of educational content and will serve as program faculty. The initiative will deliver emerging science and incorporate expert opinions on best practices for the diagnosis and management of patients with HRS.
Please select “Register/Take Course” to complete the following:
- Program Evaluation
Upon completion, you will receive your accreditation certificate.
The pre-test will close on Monday, March 6, at 6:15 PM CT.
The post-program activities will become available on Monday, March 6, at 7:00 PM CT.
This activity has been designed to meet the educational needs of hepatologists, nephrologists, intensivists, hospitalists, and pharmacists involved in the care of patients with hepatorenal syndrome (HRS).
After completing this activity, the participant should be better able to:
- Implement an early proactive diagnosis of HRS considering new guidelines (i.e., AASLD 2021, ACG 2022)
- Discuss the proper fluid status assessment and management, specifically regarding albumin
- Deliver the management of HRS considering new treatment options, outcomes of interest
This activity is jointly provided by Medical Education Resources and the Chronic Liver Disease Foundation.
Supported by an educational grant from Mallinckrodt Pharmaceuticals.
|In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Chronic Liver Disease Foundation (CLDF). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.|
Medical Education Resources designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Relevant Financial Relationships
It is the policy of Medical Education Resources to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are mitigated by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
There is no fee for this educational activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 AMA PRA Category 1 Credit™ (Non- MD)